Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
-0.20%
617.98
-1.23
-0.20%
619.21618.96618.96615.58
SX6P
Utilities
SX6P
Utilities
SX6P
+0.79%
535.06
+4.20
+0.79%
530.86530.03535.89526.25
SX8P
Technology
SX8P
Technology
SX8P
-0.03%
930.37
-0.25
-0.03%
930.62924.86935.91921.75
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.82%
447.76
-8.29
-1.82%
456.05452.80452.80446.45
SXDP
Health Care
SXDP
Health Care
SXDP
-0.63%
1,083.75
-6.88
-0.63%
1,090.631,086.801,086.801,078.00
SXEP
Energy
SXEP
Energy
SXEP
+1.71%
544.51
+9.17
+1.71%
535.34536.16545.03536.16
SXFP
Financials
SXFP
Financials
SXFP
-0.35%
887.07
-3.16
-0.35%
890.23887.34889.41883.68
SXKP
Communications
SXKP
Communications
SXKP
+0.99%
315.87
+3.09
+0.99%
312.78311.95316.04310.80
SXNP
Industrials
SXNP
Industrials
SXNP
-0.65%
1,088.51
-7.09
-0.65%
1,095.601,090.801,091.751,082.31
SXPP
Materials
SXPP
Materials
SXPP
-0.47%
814.26
-3.81
-0.47%
818.07813.89815.76804.46
SPRY:NASDAQ
ARS Pharmaceuticals Inc
$7.42
-6.49%
(-0.51) 1D
$7.34
-1.09% (-0.081)
Pre-market
Closed: May 15, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPRY...
Open
$7.40
High
$7.81
Low
$7.03
Mkt. cap
737.31M
Avg. vol.
1.64M
Volume
4.36K
52-wk high
$18.89
52-wk low
$6.66
EPS
-$1.74
Beta
0.93
Shares outstanding
99.30M
No. of employees
157
News stories
From sources across the web
About ARS Pharmaceuticals Inc
CEO-
Employees157
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.72M
32.50M
28.09M
22.68M
Cost of goods sold
9.02M
10.94M
9.60M
10.62M
Cost of revenue
9.02M
10.94M
9.60M
10.62M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.31M
74.75M
59.96M
72.20M
Operating expense
54.31M
74.75M
59.96M
72.20M
Total operating expenses
63.33M
85.69M
69.55M
82.83M
Operating income
-47.61M
-53.19M
-41.46M
-60.14M
Other non operating income
2.73M
2.04M
-3.49M
-
EBT including unusual items
-44.88M
-51.15M
-41.40M
-60.62M
EBT excluding unusual items
-44.88M
-51.15M
-36.88M
-60.62M
Income tax expense
-
-
-80.00K
-
Effective tax rate
-
-
0.19%
-
Other operating expenses
-
-
-
-
Net income
-44.88M
-51.15M
-41.32M
-60.62M
Net profit margin
-285.57%
-157.38%
-147.13%
-267.26%
Earnings per share
-0.46
-0.52
-0.42
-0.61
Interest and investment income
-
-
10.67M
1.97M
Interest expense
-
-
-2.60M
-2.44M
Net interest expenses
-
-
8.07M
-473.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-47.34M
-52.80M
-41.05M
-59.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more